When re-stratifying Cohort 1 NPC patients according to clinical response, we again observed an RT-mediated increase in the abundance of CD8+ as well as CD4+ T cells expressing CCR1, CCR4 and/or CCR5 in non-recurrent NPC patients but not in recurrent patients. This evidence concerns the gene CCR4 and nasopharyngeal carcinoma.